INCR Stock Overview
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.
+ 1 more risk
InterCure Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₪4.60|
|52 Week High||₪16.69|
|52 Week Low||₪3.95|
|1 Month Change||9.26%|
|3 Month Change||-21.72%|
|1 Year Change||-72.12%|
|3 Year Change||-71.02%|
|5 Year Change||-80.52%|
|Change since IPO||-100.00%|
Recent News & Updates
These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably WellFeb 16
What InterCure Ltd.'s (TLV:INCR) P/E Is Not Telling YouSep 19
Here's Why InterCure (TLV:INCR) Can Manage Its Debt ResponsiblyAug 22
InterCure (TLV:INCR) Seems To Use Debt Quite SensiblyFeb 14
These 4 Measures Indicate That InterCure (TLV:INCR) Is Using Debt Reasonably WellSep 11
What Percentage Of InterCure Ltd (TLV:INCR) Shares Do Insiders Own?Mar 08
Shareholders Are Raving About How The InterCure (TLV:INCR) Share Price Increased 936%Jan 12
Is InterCure (TLV:INCR) Using Debt Sensibly?Dec 04
|INCR||IL Pharmaceuticals||IL Market|
Return vs Industry: INCR underperformed the IL Pharmaceuticals industry which returned -56.7% over the past year.
Return vs Market: INCR underperformed the IL Market which returned -10.4% over the past year.
|INCR Average Weekly Movement||7.8%|
|Pharmaceuticals Industry Average Movement||4.9%|
|Market Average Movement||5.7%|
|10% most volatile stocks in IL Market||9.3%|
|10% least volatile stocks in IL Market||3.9%|
Stable Share Price: INCR is more volatile than 75% of IL stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: INCR's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector.
InterCure Ltd. Fundamentals Summary
|INCR fundamental statistics|
Is INCR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|INCR income statement (TTM)|
|Cost of Revenue||₪255.78m|
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
|Earnings per share (EPS)||0.46|
|Net Profit Margin||5.04%|
How did INCR perform over the long term?See historical performance and comparison